Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Clinical trial NCT06911944 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06911944
Sponsor: Michael Rafii, MD, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease Amyloid Beta Protein

Start date: 2026-08-01
Primary completion: 2028-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.